Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-037544

Co-Chief Executive Officer sold 15,500 shares at $14.69 ($227,618)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Klee Justin B. Co-Chief Executive Officer 2026-02-02 Sale −15,500 $14.69 $227,618 3,363,898 D: show line 1 in the form
Open-market sales · 15,500 sh · avg $14.69 · $227,618
Loading xslF345X05/ownership.xml…